Search results for " Ente"

showing 10 items of 547 documents

Small-Bowel Diagnosis in Patients with Familial Adenomatous Polyposis: Comparison of Push Enteroscopy, Capsule Endoscopy, Ileoscopy, and Enteroclysis

2009

BACKGROUND: Conventional upper endoscopy (EGD), EGD with side-view endoscope and ileoscopy are established procedures for endoscopic evaluation of patients with familial adenomatous polyposis (FAP). However, we still have little data on the frequency and relevance of adenomas in those parts of the small bowel which are not accessible to EGD and ileoscopy. Adenomas distal to the duodenum are found more often in FAP patients with known duodenal adenomas. The question is, whether these patients can benefit from additional endoscopic and/or radiographic examinations. METHODS: Between July 2001 and August 2006 we performed comparative small bowel studies with push enteroscopy (PE), capsule endos…

AdultMalemedicine.medical_specialtyAdolescentendocrine system diseasesEndoscopeDuodenumBiopsyRadiographyContrast MediaCapsule EndoscopySensitivity and SpecificityGastroenterologyEndoscopy GastrointestinalFamilial adenomatous polyposislaw.inventionYoung AdultCapsule endoscopylawInternal medicineIntestine SmallmedicinePush enteroscopyHumansIn patientIntubation GastrointestinalAgedbusiness.industryGastroenterologyMiddle Agedmedicine.diseasedigestive system diseasesstomatognathic diseasesCell Transformation NeoplasticJejunummedicine.anatomical_structureAdenomatous Polyposis ColiDuodenumFemaleBarium SulfatePouchbusinessZeitschrift für Gastroenterologie
researchProduct

Accuracy of magnetic resonance enterography in the preoperative assessment of patients with Crohn's disease of the small bowel

2016

Aim to assess the accuracy of magnetic resonance-enterography in predicting the extension, location and characteristics of the small bowel segments affected by Crohn's disease. Method This is a prospective study including a consecutive series of 38 patients with small bowel Crohn's disease who underwent surgery at a specialized colorectal unit of a tertiary hospital. Preoperative magnetic resonance enterography was performed in all patients, following a homogeneous protocol, within the three months prior to surgery. A thorough exploration of the small bowel was performed during the surgical procedure, using calibration spheres, according to the discretion of the surgeon. The accuracy of mag…

AdultMalemedicine.medical_specialtyAdolescentsurgical treatmentCrohn's DiseaseConstriction Pathologic030230 surgerySensitivity and SpecificityYoung Adult03 medical and health sciences0302 clinical medicinePhlegmonCrohn Diseasesmall bowelIntestine SmallPreoperative CaremedicineHumansEndoscopy Digestive SystemProspective StudiesSurgical treatmentProspective cohort studyCrohn's diseasemagnetic resonance enterographybusiness.industryGastroenterologymedicine.diseaseMagnetic resonance enterographyequipment and suppliesMagnetic Resonance Imagingpreoperative assessmentStenosiscalibration spheresHomogeneousCalibrationFemale030211 gastroenterology & hepatologyRadiologybusinesshuman activities
researchProduct

Antiinflammatory treatment and intestinal alpha 1-antitrypsin clearance in active Crohn's disease.

1985

Intestinal alpha 1-antitrypsin clearance was quantified in 17 patients with clinically active Crohn's disease before and after a six-week period of treatment with sulfasalazine and methylprednisolone. Before the study, alpha 1-antitrypsin clearance and, hence, enteric protein loss was elevated as being above control values in 16 patients. After therapy, clearance values decreased in 11 and were normalized in five patients. Serum albumin level was normalized in 11 of 12 patients who had hypoalbuminemia before the study. Clinical condition was improved in all but 1 patient after treatment. There was no close correlation between alpha 1-antitrypsin clearance and disease activity index. These r…

AdultMalemedicine.medical_specialtyPathologyAdolescentPhysiologyProtein-Losing EnteropathiesSerum albuminAnti-Inflammatory AgentsGastroenterologyMethylprednisoloneFecesCrohn DiseaseSulfasalazineInternal medicinemedicineHumansHypoalbuminemiaIntestinal MucosaSerum AlbuminCrohn's diseasebiologybusiness.industryProtein losing enteropathyGastroenterologyAlbuminHepatologyMiddle Agedmedicine.diseasedigestive system diseasesSulfasalazineMethylprednisolonealpha 1-Antitrypsinbiology.proteinFemalebusinessmedicine.drugDigestive diseases and sciences
researchProduct

Gastric emptying of indigestible tablets in relation to composition and time of ingestion of meals studied by metal detector.

1991

Enteric-coated tablets leave the stomach mainly during the interdigestive phase. Composition as well as time of ingestion of meals may influence their gastric emptying considerably. In 12 normal volunteers gastric emptying of a plastic tablet with a metal core was followed by a metal detector in relation to different compositions and various times of ingestion of meals. With an empty stomach and after ingestion of 250 ml water, the mean time for gastric emptying of the tablet was 38 +/- 11 min (mean +/- SEM) and 38 +/- 8 min. Two hundred fifty milliliters of milk (652 kJ) and a formula diet (1000 kJ) delayed gastric emptying time to 128 +/- 14 and 152 +/- 6 min, respectively (P less than 0.…

AdultMalemedicine.medical_specialtyPhysiologyGastroenterologyEatingInternal medicinemedicineIngestionHumansEnteric coatedEating habitsMorningGastric emptyingbusiness.industryStomachdigestive oral and skin physiologyGastroenterologyMiddle AgedBioavailabilitymedicine.anatomical_structureGastric EmptyingFoodMetalsComposition (visual arts)FemaleTablets Enteric-CoatedbusinessDigestive diseases and sciences
researchProduct

Beclomethasone dipropionate in Crohn's ileitis: A randomised, double-blind trial.

2011

Abstract Background Steroids, the mainstay of Crohn's disease treatment, have been associated with systemic side effects. Aim To evaluate the efficacy and tolerability of beclomethasone dipropionate for maintaining remission induced by a short course of systemic steroids in patients with Crohn's ileitis with or without right colonic involvement. Methods Patients (n = 84) with active Crohn's disease who achieved remission during a 2-week prednisone run-in period were randomised to receive beclomethasone dipropionate for 24 weeks or continue prednisone for a further 2 weeks followed by placebo for 22 weeks. The primary outcome was relapse rate (Crohn's Disease Activity Index score > 150 and a…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaRemissionKaplan-Meier EstimateBeclomethasone dipropionate Crohn's disease RemissionPlaceboGastroenterologyDrug Administration ScheduleMedication Adherencelaw.inventionDouble blindCrohn DiseaseDouble-Blind MethodRandomized controlled triallawPrednisoneInternal medicineSecondary PreventionmedicineHumansIleitisAdverse effectGlucocorticoidsAgedCrohn's diseaseHepatologybusiness.industryRemission InductionBeclomethasoneGastroenterologyBeclomethasone dipropionate Crohn's ileitis:.Middle Agedmedicine.diseaseSurgeryBeclomethasone dipropionateCrohn's diseaseTreatment OutcomeTolerabilityPrednisoneFemaleTablets Enteric-Coatedbusinessmedicine.drug
researchProduct

Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study

2017

AIM To report adalimumab (Ada) efficacy on articular-gastrointestinal disease and health-related quality of life (HRQoL) in patients with enteropathic spondyloarthritis (ES). METHODS A cohort of 52 patients with ES was evaluated in the departments of gastroenterology and internal medicine. At baseline, all patients underwent assessment by an integrated gastro-rheumatologic evaluation of articular and gastrointestinal activity, as well patient reported outcomes (PROs) of the HRQoL questionnaires. After this integrated evaluation and following a specific working flowchart, the Ada anti-tumor necrosis factor (TNF)-inhibitor was assigned to a cohort of 30 patients and its clinical efficacy was …

AdultMalemedicine.medical_specialtyTime FactorsTumor necrosis factor-inhibitorMultidisciplinary studyObservational StudyInflammatory bowel diseasesInflammatory bowel diseaseWorkflowEnteropathic spondyloarthriti03 medical and health sciences0302 clinical medicineCrohn DiseaseClinimetric assessmentInternal medicineSpondylarthritisTumor necrosis factor-inhibitorsAdalimumabHumansMedicinePatient Reported Outcome MeasuresPatient reported outcomes030203 arthritis & rheumatologyBiological ProductsTumor Necrosis Factor-alphabusiness.industryRemission InductionAdalimumabGastroenterologyInflammatory Bowel DiseasesGeneral MedicineMiddle AgedPatient reported outcomeEnteropathic spondyloarthritisClinimetric assessment; Enteropathic spondyloarthritis; Inflammatory bowel diseases; Multidisciplinary evaluation; Patient reported outcomes; Tumor necrosis factor-inhibitors; GastroenterologyTreatment OutcomeMultidisciplinary evaluationAntirheumatic AgentsCritical PathwaysQuality of LifeColitis UlcerativeFemale030211 gastroenterology & hepatologyObservational studybusinessmedicine.drug
researchProduct

Interaction between cannabinoid CB1 receptors and endogenous ATP in the control of spontaneous mechanical activity in mouse ileum

2009

Background and purpose Although it is well accepted that cannabinoids modulate intestinal motility by reducing cholinergic neurotransmission mediated by CB(1) receptors, it is not known whether the endocannabinoids are involved in more complex circuits and if they interact with other systems. The aim of the present study was to examine possible interactions between cannabinoid CB(1) receptors and purines in the control of spontaneous contractility of longitudinal muscle in mouse ileum. Experimental approach The mechanical activity of longitudinally oriented ileal segments from mice was recorded as isometric contractions. Key results The selective CB(1) receptor agonist, N-(2-chloroethyl)5,8…

AgonistMalemedicine.medical_specialtyP2Y receptormedicine.drug_classmedicine.medical_treatmentCB(1) receptorArachidonic AcidsP2 receptorBiologyIn Vitro TechniquesSettore BIO/09 - FisiologiaMiceAdenosine TriphosphateReceptor Cannabinoid CB1IleumInternal medicinemedicineAnimalsReceptorP2X receptors: enteric nervous systemcholinergic transmissionPharmacologypurineDose-Response Relationship DrugPurinergic receptorcannabinoidReceptor antagonistAdenosine receptorResearch PapersBiomechanical PhenomenaATPMice Inbred C57BLEndocrinologyCannabinoidGastrointestinal MotilityProtein Binding
researchProduct

GLP-2: What do we know? What are we going to discover?

2014

Glucagon-like peptide 2 [GLP-2] is a 33-amino acid peptide released from the mucosal enteroendocrine L-cells of the intestine. The actions of GLP-2 are transduced by the GLP-2 receptor [GLP-2R], which is localized in the neurons of the enteric nervous system but not in the intestinal epithelium, indicating an indirect mechanism of action. GLP-2 is well known for its trophic role within the intestine and interest in GLP-2 is now reviving based on the approval of the GLP-2R agonist for treatment of short bowel syndrome [SBS]. Recently it also seems to be involved in glucose homeostasis. The aim of this review is to outline the importance of neuroendocrine peptides, specifically of GLP-2 in th…

Agonistendocrine systemmedicine.medical_specialtyPhysiologymedicine.drug_classClinical BiochemistryEnteroendocrine cellBiologySettore BIO/09 - FisiologiaBiochemistryEnteric Nervous SystemCellular and Molecular NeuroscienceEndocrinologyInternal medicineGlucagon-Like Peptide 2medicineAnimalsHumansGlucose homeostasisReceptorInflammationdigestive oral and skin physiologyShort bowel syndromemedicine.diseaseIntestinal epitheliumGastrointestinal TractEndocrinologyGLP-2 GLP-2 receptor gastrointestinal tract enteric nervous systemEnteric nervous systemGastrointestinal functionNeurosciencehormones hormone substitutes and hormone antagonistsSignal TransductionRegulatory Peptides
researchProduct

Parte II Cap. I L'impresa agricola

2021

This chapter takes into account the transformations that have taken place with regard to the discipline of the agricultural enterprise and its new functions

Agricultural enterprise - multifunctionality
researchProduct

Enterococcal meningitis caused by Enterococcus casseliflavus. First case report

2005

Abstract Background Enterococcal meningitis is an uncommon disease usually caused by Enterococcus faecalis and Enterococcus faecium and is associated with a high mortality rate. Enterococcus casseliflavus has been implicated in a wide variety of infections in humans, but never in meningitis. Case presentation A 77-year-old Italian female presented for evaluation of fever, stupor, diarrhea and vomiting of 3 days duration. There was no history of head injury nor of previous surgical procedures. She had been suffering from rheumatoid arthritis for 30 years, for which she was being treated with steroids and methotrexate. On admission, she was febrile, alert but not oriented to time and place. H…

BACTEREMIACase ReportMicrobial Sensitivity TestsVANCOMYCIN-RESISTANT ENTEROCOCCI; CLINICAL-FEATURES; BACTEREMIA; GALLINARUM; MOTILE ENTEROCOCCUS; OUTCOMESMeropenemEnterococcus faecalisVANCOMYCIN-RESISTANT ENTEROCOCCIlcsh:Infectious and parasitic diseaseslaw.inventionMicrobiologyMeningitis BacteriallawAmpicillinmedicineEnterococcus casseliflavusHumanslcsh:RC109-216Gram-Positive Bacterial InfectionsAgedCerebrospinal FluidOUTCOMESSigmoid Diseasesbiologybusiness.industryCLINICAL-FEATURESMeropenembiochemical phenomena metabolism and nutritionbiology.organism_classificationmedicine.diseaseAnti-Bacterial AgentsMOTILE ENTEROCOCCUSInfectious DiseasesGram stainingEnterococcusSulbactamGALLINARUMAmpicillinFemaleThienamycinsbusinessMeningitisEnterococcusmedicine.drugEnterococcus faeciumBMC Infectious Diseases
researchProduct